Page 129 - Read Online

Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, N-Myc downstream-regulated gene 4 (NDRG4): a candidate
Kigawa G, Nemoto H, Sanada Y. Methylation of the MGMT tumor suppressor gene and potential biomarker for colorectal
gene is frequently detected in advanced gastric carcinoma. cancer. J Natl Cancer Inst 2009;101:916-27.
Anticancer Res 2009;29:5053-5. 121. Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, Ofner A,
110. Kitajima Y, Ohtaka K, Mitsuno M, Tanaka M, Sato S, Crispin A, Neumann J, Lamerz R, Kolligs FT. Methylation of
Nakafusa Y, Miyazaki K. Helicobacter pylori infection is NEUROG1 in serum is a sensitive marker for the detection of
an independent risk factor for Runx3 methylation in gastric early colorectal cancer. Am J Gastroenterol 2011;106:1110-8.
cancer. Oncol Rep 2008;19:197-202. 122. Zou H, Yu B, Zhao R, Wang Z, Cang H, Li D, Feng G,
111. Lu XX, Yu JL, Ying LS, Han J, Wang S, Yu QM, Wang XB, Yi J. Detection of aberrant p16 methylation in the serum of
Fang XH, Ling ZQ. Stepwise cumulation of RUNX3 colorectal cancer patients. Zhonghua Yu Fang Yi Xue Za Zhi
methylation mediated by Helicobacter pylori infection 2002;36:499-501.
contributes to gastric carcinoma progression. Cancer 123. Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H,
2012;118:5507-17. Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR,
112. Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Matsubara N, Goel A. Analysis of fecal DNA methylation
Campbell ME, Oberg AL, Ahlquist DA. Highly methylated to detect gastrointestinal neoplasia. J Natl Cancer Inst
genes in colorectal neoplasia: implications for screening. 2009;101:1244-58.
Cancer Epidemiol Biomarkers Prev 2007;16:2686-96. 124. Tan SH, Ida H, Lau QC, Goh BC, Chieng WS, Loh M, Ito Y.
113. Ebert MP, Model F, Mooney S, Hale K, Lograsso J, Detection of promoter hypermethylation in serum samples
Tonnes-Priddy L, Hoffmann J, Csepregi A, Rocken C, of cancer patients by methylation-specifi c polymerase chain
Molnar B, Schulz HU, Malfertheiner P, Lofton-Day C. reaction for tumour suppressor genes including RUNX3.
Aristaless-like homeobox-4 gene methylation is a potential Oncol Rep 2007;18:1225-30.
marker for colorectal adenocarcinomas. Gastroenterology 125. Oh T, Kim N, Moon Y, Kim MS, Hoehn BD, Park CH,
2006;131:1418-30. Kim TS, Kim NK, Chung HC, An S. Genome-wide
114. Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, identifi cation and validation of a novel methylation biomarker,
Park J, Kim DH. Aberrant methylation of APC, MGMT, SDC2, for blood-based detection of colorectal cancer.
RASSF2A, and Wif-1 genes in plasma as a biomarker J Mol Diagn 2013;15:498-507.
for early detection of colorectal cancer. Clin Cancer Res 126. Li M, Chen WD, Papadopoulos N, Goodman SN,
2009;15:6185-91. Bjerregaard NC, Laurberg S, Levin B, Juhl H, Arber N,
115. Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Moinova H, Durkee K, Schmidt K, He Y, Diehl F,
Taylor WR, Butz ML, Thibodeau SN, Rabeneck L, Paszat LF, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW,
Kinzler KW, Vogelstein B, Bjerregaard NC, Laurberg S, Markowitz SD, Vogelstein B. Sensitive digital quantifi cation
Sorensen HT, Berger BM, Lidgard GP. Next-generation of DNA methylation in clinical samples. Nat Biotechnol
stool DNA test accurately detects colorectal cancer and large 2009;27:858-63.
adenomas. Gastroenterology 2012;142:248-56. 127. Ahn JB, Chung WB, Maeda O, Shin SJ, Kim HS, Chung HC,
116. Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Kim NK, Issa JP. DNA methylation predicts recurrence
Thibodeau SN, Boardman LA, Berger BM, Lidgard GP. The from resected stage III proximal colon cancer. Cancer
stool DNA test is more accurate than the plasma septin 9 test 2011;117:1847-54.
in detecting colorectal neoplasia. Clin Gastroenterol Hepatol 128. Wallner M, Herbst A, Behrens A, Crispin A, Stieber P,
2012;10:272-7e1. Goke B, Lamerz R, Kolligs FT. Methylation of serum DNA
117. Yamaguchi S, Asao T, Nakamura J, Ide M, Kuwano H. High is an independent prognostic marker in colorectal cancer.
frequency of DAP-kinase gene promoter methylation in Clin Cancer Res 2006;12:7347-52.
colorectal cancer specimens and its identifi cation in serum. 129. Katoh H, Yamashita K, Waraya M, Margalit O, Ooki A,
Cancer Lett 2003;194:99-105. Tamaki H, Sakagami H, Kokubo K, Sidransky D, Watanabe M.
118. Hellebrekers DM, Lentjes MH, van den Bosch SM, Epigenetic silencing of HOPX promotes cancer progression in
Melotte V, Wouters KA, Daenen KL, Smits KM, Akiyama Y, colorectal cancer. Neoplasia 2012;14:559-71.
Yuasa Y, Sanduleanu S, Khalid-de Bakker CA, Jonkers D, 130. Jensen LH, Rasmussen AA, Byriel L, Kuramochi H,
Weijenberg MP, Louwagie J, van Criekinge W, Carvalho B, Cruger DG, Lindebjerg J, Danenberg PV, Jakobsen A,
Meijer GA, Baylin SB, Herman JG, de Bruine AP, van Danenberg K. Regulation of MLH1 mRNA and protein
Engeland M. GATA4 and GATA5 are potential tumor expression by promoter methylation in primary colorectal
suppressors and biomarkers in colorectal cancer. Clin Cancer cancer: a descriptive and prognostic cancer marker study.
Res 2009;15:3990-7. Cell Oncol (Dordr) 2013;36:411-9.
119. Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, 131. Nilsson TK, Lof-Ohlin ZM, Sun XF. DNA methylation of
Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y, Itoh F, the p14ARF, RASSF1A and APC1A genes as an independent
Imai K, Sugai T, Shen L, Issa JP, Shinomura Y, Tokino T, prognostic factor in colorectal cancer patients. Int J Oncol
Toyota M. IGFBP7 is a p53-responsive gene specifi cally 2013;42:127-33.
silenced in colorectal cancer with CpG island methylator 132. Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H,
phenotype. Carcinogenesis 2010;31:342-9. Sanada Y. Detection of TFPI2 methylation in the serum of
120. Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, colorectal cancer patients. Cancer Lett 2011;311:96-100.
de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, 133. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT,
Stessels F, Louwagie J, Smits KM, Weijenberg MP, Schernhammer ES, Giovannucci EL, Fuchs CS. A cohort
Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, study of tumoral LINE-1 hypomethylation and prognosis in
Jonkers DM, Herman JG, de Bruine AP, van Engeland M. colon cancer. J Natl Cancer Inst 2008;100:1734-8.

122 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦